Related Experiment Videos
Aberrant cell cycle regulation in cervical carcinoma
1Department of Obstetrics and Gynecology, Women's Cancer Clinic, Women's life and Science Institute, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea. ytkchoi@yumc.yonsei.ac.kr
Yonsei Medical Journal
|November 1, 2005
Summary
Human papillomaviruses (HPV) are key to cervical cancer, but progression involves genetic changes. Aberrant cell cycle protein regulation, including cyclins and cyclin-dependent kinases (CDKs), is characteristic of HPV-driven cervical cancers.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Cervical cancer is a common women's malignancy worldwide.
- Human papillomaviruses (HPV) are the primary cause of cervical cancer.
- Cancer development involves multiple genetic and epigenetic events, particularly cell cycle alterations.
Purpose of the Study:
- To investigate the role of cell cycle regulation in cervical carcinogenesis.
- To understand the impact of HPV infection on cell cycle proteins.
Main Methods:
- Review of studies on cell cycle proteins in cervical cancer.
- Analysis of aberrant regulation of proteins in HPV-infected cells and precursors.
Main Results:
- Cell cycle control in mammals relies on cyclins and cyclin-dependent kinases (CDKs).
- Key pathways like p16INK4A-cyclin D1-CDK4/6-pRb-E2F are involved.
- HPV-infected cervical cancers show altered levels of cyclin D, cyclin E, p16INK4A, p21WAF1, and p27KIP1.
Conclusions:
- Aberrant regulation of cell cycle proteins is a hallmark of HPV-associated cervical cancer.
- Interactions between viral oncoproteins (HPV E6/E7) and host cell proteins are critical for cervical carcinogenesis.